Ser32
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.8
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser32  -  MCM4 (mouse)

Site Information
RsEESRSsPNRRRRG   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 450001

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 , 2 ) , phospho-antibody ( 3 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Putative in vivo kinases:
CDK1 (mouse) ( 3 )

References 

1

Degryse S, et al. (2017) Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia. Leukemia
28852199   Curated Info

2

Pinto SM, et al. (2015) Quantitative phosphoproteomic analysis of IL-33-mediated signaling. Proteomics 15, 532-44
25367039   Curated Info

3

Komamura-Kohno Y, et al. (2006) Site-specific phosphorylation of MCM4 during the cell cycle in mammalian cells. FEBS J 273, 1224-39
16519687   Curated Info